These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31436592)

  • 21. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
    Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
    Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varicella virus and the herpes zoster vaccine. A review of Zostavax and the new AFIP recommendations.
    Ebede TL; Zippin JH
    J Drugs Dermatol; 2008 Dec; 7(12):1173-6. PubMed ID: 19137773
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: a randomised non-inferiority clinical trial.
    Diez-Domingo J; Weinke T; Garcia de Lomas J; Meyer CU; Bertrand I; Eymin C; Thomas S; Sadorge C
    Vaccine; 2015 Feb; 33(6):789-95. PubMed ID: 25555381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.
    Miller G; Schaefer H; Yoder S; Miller R; Winokur P; Kotloff K; Klassen D; Wierzbicki M; Amegashie C; Edwards K
    Transpl Infect Dis; 2018 Jun; 20(3):e12874. PubMed ID: 29512282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
    Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
    J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Just say no to shingles! The zoster vaccine: update for the clinical nurse specialist.
    O'Malley P
    Clin Nurse Spec; 2011; 25(6):281-3. PubMed ID: 22016014
    [No Abstract]   [Full Text] [Related]  

  • 28. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
    Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
    J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the effectiveness of zoster vaccine live: A retrospective cohort study using primary care data in the United Kingdom.
    Matthews I; Lu X; Dawson H; Bricout H; O'Hanlon H; Yu E; Nozad B
    Vaccine; 2018 Nov; 36(46):7105-7111. PubMed ID: 30195489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.
    Weaver BA;
    J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The immunogenicity and safety of zoster vaccine in Taiwanese adults.
    Yao CA; Chen LK; Huang KC
    Vaccine; 2015 Mar; 33(13):1515-7. PubMed ID: 25681662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Zoster vaccine].
    Wutzler P
    Klin Monbl Augenheilkd; 2010 May; 227(5):384-7. PubMed ID: 20490991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
    Alexander KE; Tong PL; Macartney K; Beresford R; Sheppeard V; Gupta M
    Vaccine; 2018 Jun; 36(27):3890-3893. PubMed ID: 29807711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RF-New Recombinant Vaccine for the Prevention of Herpes Zoster.
    Morgado-Carrasco D; Fustà-Novell X; Giavedoni P
    Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):67-68. PubMed ID: 31387689
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevent shingles with Zostavax.
    Laustsen G; Neilson T
    Nurse Pract; 2007 Jun; 32(6):6-7. PubMed ID: 17557014
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pain in herpes zoster: Prevention and treatment].
    Calvo-Mosquera G; González-Cal A; Calvo-Rodríguez D; Primucci CY; Plamenov-Dipchikov P
    Semergen; 2017; 43(4):318-327. PubMed ID: 27053513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study: shingles vaccine safe for patients on immune-suppressing drugs.
    Hum Vaccin Immunother; 2012 Aug; 8(8):1015-6. PubMed ID: 23359877
    [No Abstract]   [Full Text] [Related]  

  • 38. Assessing herpes zoster vaccine efficacy in patients with diabetes: A community-based cohort study.
    Kornelius E; Lo SC; Huang CN; Wang CC; Wang YH; Yang YS
    J Med Virol; 2024 May; 96(5):e29667. PubMed ID: 38738524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes zoster: The changing landscape.
    Caldera F; Ninos CL; Hayney MS
    J Am Pharm Assoc (2003); 2017; 57(2):281-283. PubMed ID: 28285776
    [No Abstract]   [Full Text] [Related]  

  • 40. Review of the Persistence of Herpes Zoster Vaccine Efficacy in Clinical Trials.
    Cook SJ; Flaherty DK
    Clin Ther; 2015 Nov; 37(11):2388-97. PubMed ID: 26602282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.